Core Scientific (CORZZ) EBITDA (2020 - 2026)

Core Scientific's EBITDA history runs 7 years deep, the most recent figure standing at -$310.4 million for Q1 2026.

• In Q1 2026, EBITDA fell 559.94% year-over-year to -$310.4 million; the TTM figure through Mar 2026 stood at -$509.0 million (down 108.31% YoY), while the FY2025 annual figure was -$245.6 million, down 72.87% from the prior year.
• EBITDA came in at -$310.4 million for Q1 2026 at Core Scientific, down from -$117.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $55.2 million in Q1 2024 to a low of -$1.0 billion in Q2 2022.
• A 5-year average of -$164.6 million and a median of -$47.0 million in 2025 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 8489.92% in 2022 and soared 626.48% in 2024, its largest moves.
• Core Scientific's EBITDA stood at -$636.1 million in 2022, then surged by 100.62% to $3.9 million in 2023, then plunged by 1762.2% to -$65.4 million in 2024, then slumped by 79.65% to -$117.5 million in 2025, then plunged by 164.25% to -$310.4 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$310.4 million, -$117.5 million, and -$54.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison